Investment Insights: Tanaka Capital Management's Q3 2022 vs. Q4 2022 holdings comparison

As the saying goes, "change is the only constant." This holds true even in the world of investments. In this blog post, we will be discussing the changes in Tanaka Capital Management Inc's holdings between Q3 2022 and Q4 2022. Tanaka Capital Management is a renowned investment management firm that manages a variety of investment vehicles for both institutions and individuals. As we go through the changes in their holdings, we will gain insights into their investment philosophy and strategy.

In Q4 2022, Tanaka Capital Management held shares of 37 different companies. Among these, "Apple Computing" was the largest holding with a total of 46,320 shares, followed by "Amyris" with 1,963,171 shares. However, compared to Q3 2022, both these holdings saw a slight decrease of 1% and 2.5%, respectively. In terms of value, Apple's Q3 2022 value was $6,425,000 which decreased by 6.3% to $6,018,000 in Q4 2022. Contrastingly, Amyris' Q3 2022 value was $55,850,000 which saw a decrease of 46.2% to $30,040,000 in Q4 2022.

In this comparison, "BeyondSpring Inc" witnessed the highest increase of 77.4% in shares held by Tanaka Capital Management. The company had 31,153 shares in Q3 2022, which increased to 29,473 shares in Q4 2022. In terms of value, BeyondSpring's Q3 2022 value was $31,000 which increased by 77.4% to $55,000 in Q4 2022.

Another notable change was seen in "Nvidia" and "Philip Morris International." Nvidia's shares held by Tanaka Capital Management increased from 1,620 in Q3 2022 to 1,620 in Q4 2022, with an increase in value from $197,000 to $237,000. In contrast, Philip Morris International's shares remained constant at 6,996, but the value increased from $581,000 to $708,000, representing a change of 21.9%.

On the other hand, Tanaka Capital Management decreased their holdings in "Tesla, Inc." and "Corcept Therapeutics" between Q3 2022 and Q4 2022. Tesla's shares held decreased by 0.4% from 7,245 to 7,216; however, the value saw a decrease of 53.7%, from $1,922,000 to $889,000. Similarly, Corcept Therapeutics' shares held decreased by 20.7% from 35,539 to 35,539, and the value decreased by 20.7% from $911,000 to $722,000.

It is worth mentioning that Tanaka Capital Management liquidated their holdings in "Fuelnation, Inc." and "Liminal BioSciences" in Q4 2022. As per the Q3 2022 holdings report, Tanaka Capital Management held 251,150 shares of "Fuelnation, Inc.," which was valued at $0. However, in Q4 2022, they liquidated all their holdings in the company. Similarly, they held 22 shares of "Liminal BioSciences" in Q3 2022, which were liquidated in Q4 2022.

In conclusion, we can see that Tanaka Capital Management made some significant changes to their holdings in Q4 2022 compared to Q3 2022. While they decreased their holdings in some companies, they also increased them in some others. This shows that they have a dynamic investment strategy that can adapt to changing market conditions. As investors, we can learn from their approach and strive to invest with a long-term perspective. After all, investments are not a sprint; they are a marathon.